Nanomedicine Market Shares, Strategies and Forecast Worldwide, 2017 to 2023 – The Haitian-Caribbean News Network

Posted on November 27, 2020 by Prof Baldwin

Overview:

Nanomedicineis an offshoot of nanotechnology, and refers to highly-specific medical intervention at the molecular scale for curing diseases or repairing damaged tissues. Nanomedicine uses nano-sized tools for the diagnosis, prevention and treatment of disease, and to gain increased understanding of the complex underlying pathophysiology of the disease. It involves three nanotechnology areas of diagnosis, imaging agents, and drug delivery with nanoparticles in the 11,000 nm range, biochips, and polymer therapeutics.

Click Here to Get Sample Premium Report @https://www.trendsmarketresearch.com/report/sample/9807

Majority of nanomedicines prescribedcurrently, allow oral drug delivery and its demand is increasing significantly. Although these nanovectors are designed to translocate across the gastrointestinal tract, lung, and bloodbrain barrier, the amount of drug transferred to the organ is lower than 1%; therefore improvements are challenging. Nanomedicines are designed to maximize the benefit/risk ratio, and their toxicity must be evaluated not only by sufficiently long term in vitro and in vivo studies, but also pass multiple clinical studies.

Market Analysis:

The Global Nanomedicine Market is estimated to witness a CAGR of 17.1% during the forecast period 20172023. The nanomedicine market is analyzed based on two segments therapeutic applications and regions.

The major drivers of the nanomedicine market include its application in various therapeutic areas, increasing R&D studies about nanorobots in this segment, and significant investments in clinical trials by the government as well as private sector. The Oncology segment is the major therapeutic area for nanomedicine application, which comprised more than 35% of the total market share in 2016. A major focus in this segment is expected to drive the growth of the nanomedicine market in the future.

Regional Analysis:

The regions covered in the report are the Americas, Europe, Asia Pacific, and Rest of the World (ROW). The Americas is set to be the leading region for the nanomedicine market growth followed by Europe. The Asia Pacific and ROW are set to be the emerging regions. Japan is set to be the most attractive destination and in Africa, the popularity and the usage of various nano-drugs are expected to increase in the coming years. The major countries covered in this report are the US, Germany, Japan, and Others.

Therapeutic Application Analysis:

Nanomedicines are used as fluorescent markers for diagnostic and screening purposes. Moreover, nanomedicines are introducing new therapeutic opportunities for a large number of agents that cannot be used effectively as conventional oral formulations due to poor bioavailability. The therapeutic areas for nanomedicine application are Oncology, Cardiovascular, Neurology, Anti-inflammatory, Anti-infectives, and various other areas. Globally, the industry players are focusing significantly on R&D to gain approval for various clinical trials for future nano-drugs to be commercially available in the market. The FDA should be relatively prepared for some of the earliest and most basic applications of nanomedicine in areas such as gene therapy and tissue engineering. The more advanced applications of nanomedicine will pose unique challenges in terms of classification and maintenance of scientific expertise.

Key Players:

Merck & Co. Inc., Hoffmann-La Roche Ltd., Gilead Sciences Inc., Novartis AG, Amgen Inc., Pfizer Inc., Eli Lilly and Company, Sanofi, Nanobiotix SA, UCB SA and other predominate & niche players.

Competitive Analysis:

At present, the nanomedicine market is at a nascent stage but, a lot of new players are entering the market as it holds huge business opportunities. Especially, big players along with the collaboration with other SMBs for clinical trials of nanoparticles and compounds are coming with new commercial targeted drugs in the market and they are expecting a double-digit growth in the upcoming years. Significant investments in R&D in this market are expected to increase and collaborations, merger & acquisition activities are expected to continue.

Benefits:

The report provides complete details about the usage and adoption rate of nanomedicines in various therapeutic verticals and regions. With that, key stakeholders can know about the major trends, drivers, investments, vertical players initiatives, government initiatives towards the nanomedicine adoption in the upcoming years along with the details of commercial drugs available in the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives the complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyze before investing or expanding the business in this market.

Here is the original post:
Nanomedicine Market Shares, Strategies and Forecast Worldwide, 2017 to 2023 - The Haitian-Caribbean News Network

Botulinum Toxin Market to Reach US$ 8,718.7 Mn by 2026, Rise in number of cases of migraine is expected to drive the market – BioSpace

Posted on March 25, 2022 by Prof Baldwin

Albany NY, United States: The pressing need for quality and the identification of new applications sustains the competition in the global botulinum toxin market, says a recent report by Transparency Market Research (TMR). Most companies are focused on investing in research to identify new applications that could help them get advantage and gain a greater share in the global botulinum toxin market. At the same time, considering the current applications of the product, the need for high quality is invoking companies to adopt quality control techniques.

Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=26132

On the other hand, rising requirement from specific sections of the healthcare industry is also promoting companies to step up production. The key players in the global botulinum toxin market are Allergan, Inc., Ipsen Group, Merz Pharma GmbH & Co. KGaA, Medytox, Inc., US Worldmed, LLC, Galderma, Metabiologics, Inc. (US), Lanzhou Institute of Biological Products Co. Ltd., and Revance Therapeutics.

According to TMR analysts, the global botulinum toxin market is expected to grow to a value of US$ 8,718.7 mn by the end of 2026. The analysts predict that this will happen as the market will grow a stable CAGR of 7.6% during the forecast period of 2018-2026.

Further, the botulinum toxin type A is expected to lead the global market for botulinum toxin during the forecast period. According to TMR report, the segment will alone account for 82% of the sales in the coming years, that will reap revenues of US$ 7,153.5 bn by the end of 2026. When it comes to geography, North America is predicted to be the leader in the coming years.

Request for Covid-19 Impact Analysis: https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=26132

Cosmetics and Neurology to Drive the Global Botulinum Toxin Market

Appearance has become an important aspect for every person today. So much so that people are willing to go an extra mile to make them look good. As a result, the need for products that solve problems regarding facial appearance are growing in importance. This stokes demand for products in the global botulinum toxin market. They are preferred because they are capable of fixing problems like spasticity and cervical dystonia.

On the other hand, the demand for products in the neurology section of healthcare is also looking promising. This section will stoke demand as the number of neurological cases rise and doctors find new treatment applications for the product. The product is known to be helpful for certain neurological conditions, and thus can influence demand in the global botulinum toxin market.

Enquiry Before Buying: https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=26132

Research to Open New Applications in the Global Botulinum Toxin Market

While the applications of the product in the global botulinum toxin market has been found for the last three centuries, the need for fresh applications may help players find new hopes. As a result, the research and development section of most prominent players in occupied with studies aiming to find fresh applications. This will open new opportunities for the players in the global botulinum toxin market.

At the same time, players will also be looking at other key trends in the healthcare industry. This will help devise them strategies for the future and help give more credibility to the existing product line. Besides this, the growing health awareness among people, increasing access to information on social media, and the rising spending capacity in developed and emerging economies are other factors that will influence growth in the global botulinum toxin in the coming years.

The study presented above is based on a Transparency Market Research report titled Botulinum Toxin Market (Product Type - Botulinum Toxin Type A and Botulinum Toxin Type B; Application - Aesthetic, Therapeutics) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018-2026.

More Trending Reports by Transparency Market Research:

Microbiology Culture Market: According to the report, the microbiology culture market in the U.S. was valued at US$ 2.3 Bn in 2020 and is projected to expand at a CAGR of 7.8% from 2021 to 2031. Microbiology cultures play a pivotal role, and are required for quality testing and production in several industries such as biopharmaceuticals, food, water, biotechnology, cosmetic, agriculture, and various other industries.

Nanomedicine Market: Nanomedicine, a branch of nanotechnology, is used in the diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine improves medicine delivery by manipulating materials on a nanoscale. Hence, nanomedicine has aided in the treatment of various diseases. It is still in a nascent stage, with several products in the pipeline.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact

Rohit BhiseyTransparency Market Research

State Tower,

90 State Street,

Suite 700,

Albany NY - 12207

United States

USA - Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Website: https://www.transparencymarketresearch.com/

More:
Botulinum Toxin Market to Reach US$ 8,718.7 Mn by 2026, Rise in number of cases of migraine is expected to drive the market - BioSpace

Nanomedicine Against Malaria: Use of Poly-based Nanovectors for the Drug Delivery to Plasmodium – Video

Posted on March 29, 2014 by Prof Baldwin

Nanomedicine Against Malaria: Use of Poly-based Nanovectors for the Drug Delivery to Plasmodium
Speaker: Prof. Dr. Xavier Fernndez Busquets, PhD, Barcelona Centre for International Health Research, Research Associate, Institute for Bioengineering of Ca...

By: TAUVOD

Go here to see the original:

Nanomedicine Against Malaria: Use of Poly-based Nanovectors for the Drug Delivery to Plasmodium - Video

Panel – The Horizon of Nanomedicine and Targeted Drug Delivery – Video

Posted on March 29, 2014 by Prof Baldwin

Panel - The Horizon of Nanomedicine and Targeted Drug Delivery
"Clinical Nanomedicine Targeted Medicine", The European CLINAM ETPN Summit, June 23-26, 2013.

By: TAUVOD

Global Healthcare Nanotechnology (Nanomedicine) Market 2021 Production, Revenue, Price and Gross Margin Analysis with Forecasts Jumbo News – Jumbo…

Posted on June 11, 2021 by Prof Baldwin

Healthcare Nanotechnology (Nanomedicine) Market report provides strategic supports mentioned by the business specialists with market sources, amount of manufacturing cost structure, raw materials, forecasts, turnover, manufacturing outlays, latest market trends, labor cost, demands and much more. Healthcare Nanotechnology (Nanomedicine) market reportcovers a comprehensive market structure through the globe with an in-depth study of major dynamics (Drivers, Challenges, Opportunities).

Request a sample copy of the report https://www.absolutereports.com/enquiry/request-sample/14099195

Key Market Trends:

The Growth of Nanomedicine is Expected to Provide High Opportunities for the Treatment of Neurological Diseases, Over the Forecast Period

A large number of brain disorders with neurological and psychological conditions result in short-term and long-term disabilities. Recent years observed a significant number of research studies being published on methods for the synthesis of nanoparticle-encapsulated drugs within in vivo and in vitro studies. The insufficient absorbance of oral drugs administered for a range of neurological conditions, such as Alzheimers disease, Parkinson disease, tumor, neuro-AIDS, among others, opens up the necessity of nanomedicine with stem cell therapy. Some of the registered nanoparticles for the complex CNS treatment are a gold nanoparticle, lipid nanoparticle, and chitosan nanoparticles.

Other than neurological diseases, research-based progress was found in the treatment of cancers, with the scientific communities identifying new metabolic pathways to find better drug combination using nanomedicine.

North America is Expected to Hold the Largest Share in the Market

In the United States, several companies are closely observing the developments in nanostructured materials across various applications in the healthcare industry, including medical devices, to improve efficiency and efficacy. In the United States, the National Nanotechnology Initiative (NNI), which was initiated in 2000, is among the supreme bodies that manage all nanotechnology-related activities. Under the NNI, several agencies are working in collaboration with companies and universities. For instance, nano-manufacturing in Small Business Innovation Research (SBIR) programs were developed for both commercial and public use. Companies are targeting the treatment of several cancer types and infectious diseases through immunotherapy, where nanoemulsion vaccines and drugs play a significant role. In the United States, one of the major challenges associated with nanotechnology is the ability to integrate nanoscale materials into new devices and systems, along with an application of novel properties at the nano-level. Thus, most of the companies are investing in R&D. Nanotechnology is likely to play a significant role in the delivery of drugs. In the recent strategic plan presented by the NNI in 2016, several programs were identified to further advance the research and development programs, over the forecast period.

Market Overview:

Key Manufacturers Like

Scope of the Report:

Healthcare Nanotechnology (Nanomedicine) market report focuses on the latest trends in the global and regional spaces on all the significant components, including the capacity, cost, price, technology, supplies, production, profit, and competition. Moreover, the old data and present development of the Healthcare Nanotechnology (Nanomedicine) market have been given in the scope of the report. The latest trends, product portfolio, demographics, geographical segmentation, and regulatory framework of the Healthcare Nanotechnology (Nanomedicine) market have also been involved in the study.

Market Dynamics:

Inquire Or Share Your Questions If Any Before The Purchasing This Report https://www.absolutereports.com/enquiry/pre-order-enquiry/14099195

Key Questions Answered in Market Report:

Lastly, the Global Healthcare Nanotechnology (Nanomedicine) Market Research covers a complete market structure across the world with a comprehensive analysis of major key factors. This report provides planned orientations referred by the industry experts.

Purchase This Report (Price 4250 USD for single user license) https://www.absolutereports.com/purchase/14099195

Study objectives of Healthcare Nanotechnology (Nanomedicine) Market Report:

Detailed TOC of Healthcare Nanotechnology (Nanomedicine) Market Report 2019-2024:

1 INTRODUCTION1.1 Study Deliverables1.2 Study Assumptions1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS4.1 Market Overview4.2 Market Drivers4.2.1 Growing Prevalence of Cancer and Genetic and Cardiovascular Diseases4.2.2 Increasing Advancements in Nanoscale Technologies for Diagnostic Procedures4.2.3 Growing Preference for Personalized Medicines4.3 Market Restraints4.3.1 High Cost4.3.2 Stringent Regulations for Commercial Introduction4.4 Porters Five Forces Analysis4.4.1 Threat of New Entrants4.4.2 Bargaining Power of Buyers/Consumers4.4.3 Bargaining Power of Suppliers4.4.4 Threat of Substitute Products4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION5.1 By Application5.1.1 Drug Delivery5.1.2 Biomaterials5.1.3 Active Implants5.1.4 Diagnostic Imaging5.1.5 Tissue Regeneration5.1.6 Other Applications5.2 By Disease5.2.1 Cardiovascular Diseases5.2.2 Oncological Diseases5.2.3 Neurological Diseases5.2.4 Orthopedic Diseases5.2.5 Infectious Diseases5.2.6 Other Diseases5.3 Geography5.3.1 North America5.3.1.1 US5.3.1.2 Canada5.3.1.3 Mexico5.3.2 Europe5.3.2.1 France5.3.2.2 Germany5.3.2.3 UK5.3.2.4 Italy5.3.2.5 Spain5.3.2.6 Rest of Europe5.3.3 Asia-Pacific5.3.3.1 China5.3.3.2 Japan5.3.3.3 India5.3.3.4 Australia5.3.3.5 South Korea5.3.3.6 Rest of Asia-Pacific5.3.4 Middle East & Africa5.3.4.1 GCC5.3.4.2 South Africa5.3.4.3 Rest of Middle East & Africa5.3.5 South America5.3.5.1 Brazil5.3.5.2 Argentina5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE6.1 Company Profiles6.1.1 Sanofi SA6.1.2 Celegene Corporation6.1.3 CytImmune Sciences Inc.6.1.4 Johnson & Johnson6.1.5 Luminex Corporation6.1.6 Merck & Co. Inc.6.1.7 Nanobiotix6.1.8 Pfizer Inc.6.1.9 Starpharma Holdings Limited6.1.10 Taiwan Liposome Company Ltd

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Purchase This Report (Price 4250 USD for single user license) https://www.absolutereports.com/purchase/14099195

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other report :Aluminum Composite Panel (ACP) Market 2021-2026|Industry Growth, Development Strategy Pre and Post COVID-19, Worldwide Share, Size, Trends and Leading 20 Countries

Global Floral Water Market 2021: Industry Size, Growth, Segments, Revenue, Manufacturers and 2027 Forecast Research Report

Electric Bus Motor Market Analysis, Growth, Size, Share, Trends, Forecast, Supply Demand and Sales to 2026

Global Ice Cream Sticks Market 2027: Analysis by Product Types & Applications; Industry Top Players, Regions and Market Overview

Global Action Cameras Market Trend by 2026: Market Share, Segmentation, Market Growth and Competitive Landscape| Development Strategy Pre and Post COVID-19

Global PEG-150 Distearate Market 2021: by Product Types & Application, Top Manufacturer and Regional Analysis & Forecasts to 2027

Single Phase String Inverters Market Size, Share, Supply, Demand, Segments and Forecast 2021-2027 with COVID-19 Impact

Global Fireproof Sealant Market Share, Growth, Trend Analysis and Forecast from 2021-2027; Consumption Capacity by Volume and Production Value

Global Electromagnetic Coils Market 2021: Market Size, Share, Growth, Sales and Drivers Analysis Research Report 2027 with COVID-19 Impact

Global Warning Lights Market Research Report 2021: Size, Share, Growth, Trends and Forecast 2027

Global Sweet Whey Powder Market 2021|Growth Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries

Using Hybrid Nanoparticles to Deliver siRNA to Different Cell Types – AZoNano

Posted on October 31, 2021 by Prof Baldwin

Small (or short) interfering RNA (siRNA) is the predominant RNA interference (RNAi) tool used for instigating short-term silencing of protein-coding genes. Simply put, these are naturally occurring molecules that silence genes that encode specific proteins.

Image Credit: Love Employee/Shutterstock.com

This means that siRNA demonstrates significant potential for therapeutic use, given its capacity to control protein levels. However, one of the main drawbacks with siRNA is that researchers have had difficulty transmitting the molecules to the site of action in the body, the cytosol target of cells, as a result of the bodys immune response.1

To overcome the challenges associated with siRNA delivery, a team of researchers in the Netherlands has been working to develop hybrid nanoparticles that protect and transmit siRNA into target cells.

The system the team is using relies on a combination of liposomes and extracellular vesicles (EVs), which offer unique properties that package and protect siRNA against enzyme degradation.

The hybrid nanoparticles have a hydrophobic coating, thanks to the amphiphilic nature of the liposomes, which provides adequate shielding against the bodys immune response. Additionally, as EVs can easily pass through the outer membrane of a cell, the siRNA can be delivered to the site of action as intended.

The method employed by the researchers uses a dehydration technique to produce a thin lipid film which can then be rehydrated in a water-based mixture containing the EVs and siRNA. This then generates the liposome-EV-siRNA hybrid nanoparticles, which allows for a target-based delivery system.

We show that with increasing relativeEV content in our hybrids, uptake into cells becomes no longer dictated by the liposome content ... Thus, the EV surface molecules now seem to dictate which cells can internalize and process these hybrids.

Pieter Vader, Lead Researcher and Professor of Experimental Cardiology and Regenerative Medicine at the University of Utrecht

By modifying the hybrid formulation and experimenting with the liposome to EV ratio, the researchers found that it was possible to choose into which cells the siRNA would take. The team also discovered that various cell types had the capacity to receive the hybrid nanoparticles without a toxic or adverse reaction this included kidney, nerve and ovarian cell types.

The ability to alter the ratio of the liposome-EV-siRNA formulation is important in designing cell-targeting drugs as it potentially means that only diseased cell types would be targeted, reducing any risk or undesirable side-effects.

Thus, hybrid nanoparticles could integrate the functional properties of both liposomes and EVs and offer a best of both worlds particle for the therapeutic delivery of siRNA.1

The team also looked at the therapeutic outcome when the hybrid formulation was induced with EVs from a specific stem cell population: the results remarkably demonstrated recovery and healing in breast cancer cells. This shows great promise for the future of drug development, especially when designing new drugs that target cancer and degenerative diseases.

While the results of this study make significant strides for the use of hybrid nanoparticles in siRNA delivery, Vader and his team have some way to go before this treatment technology will be rolled out commercially.

Its too soon to tell where the most potential lies for our delivery system, but we know that EVs derived from progenitor cells have intrinsic regenerative properties ... Thus, regenerative medicine applications seem most logical.

Pieter Vader, Lead Researcher and Professor of Experimental Cardiology and Regenerative Medicine at the University of Utrecht

Despite being some way off commercial viability, this recent study clearly demonstrates future potential for using hybrid nanotechnology for effective drug delivery to treat various cancers and other difficult-to-treat, degenerative diseases.

Continue reading: Manifesting Multidisciplinary Nanomedicine Research with the Multiscale Metrology Suite

Evers, M., Et. Al. (2021) Functional siRNA Delivery by Extracellular VesicleLiposome Hybrid Nanoparticles.Advanced Healthcare Materials, Available at: https://doi.org/10.1002/adhm.202101202

Disclaimer: The views expressed here are those of the author expressed in their private capacity and do not necessarily represent the views of AZoM.com Limited T/A AZoNetwork the owner and operator of this website. This disclaimer forms part of the Terms and conditions of use of this website.

Originally posted here:
Using Hybrid Nanoparticles to Deliver siRNA to Different Cell Types - AZoNano

Nano-Medical Device Market To Set Phenomenal Growth and Trends By 2020-2027 | Stryker, PerkinElmer, Nektar Therapeutics, Affymetrix – Eurowire

Posted on November 19, 2020 by Prof Baldwin

Nanomedicine is the medical application of nanotechnology, and it ranges from the medicinal uses of nanomaterials and biological devices to nano electronic biosensors. However, current problems for nanomedicine involve understanding the issues related to toxicity and environmental impact of nanoscale materials (materials whose structure is on the scale of nanometers, i.e., billionths of a meter). Also, functionalities can be added to nanomaterials by interfacing them with biological molecules or structures. Thus far, the integration of nanomaterials with biology has led to the development of diagnostic devices, contrast agents, analytical tools, physical therapy applications, and drug delivery vehicles.

The report provides study at global and regional level to provide comprehensive value market analysis for the years (2017 & 2018 Historic Years, 2019 Base Year and 2020-2027 Forecast Period). TheNano-Medical DeviceMarket research report is a wide-ranging study of current trends, market growth drivers, and restraints. Each market segment is broadly analyzed at a powdered level by region (North America, Europe, Asia Pacific, Middle East & Africa, and South& Central America) to provide thorough information on the global and regional level.

Download Sample PDF Brochure of this research study at https://www.theinsightpartners.com/sample/TIPRE00011102/

Top Leading Companies

1. Affymetrix2. Crucell N.V.3. Flamel Technologies S.A.4. Nektar Therapeutics5. Par Pharmaceutical companies Inc.6. PerkinElmer7. St.Jude Medical8. Starkey Hearing Technologies9. Starpharma Holdings limited10. Stryker Corporation

Our expert team is consistently working on updated data and information on the key players related business processes that value the market. For future strategies and predictions, we provide a special section regarding the COVID-19 situation.

The research provides answers to the following key questions:

The Insight Partners Nano-Medical Device Market Research Report Scenario includes:

Place a Purchase Order to Buy a Complete Copy of this Report @ https://www.theinsightpartners.com/buy/TIPRE00011102/

About Us:

The Insight Partners is a one-stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Life Science, Technology, Healthcare, Manufacturing, Automotive and Defense, Food Beverages, Chemical etc.

Call: +1-646-491-9876

Email:[emailprotected]

Read the original:
Nano-Medical Device Market To Set Phenomenal Growth and Trends By 2020-2027 | Stryker, PerkinElmer, Nektar Therapeutics, Affymetrix - Eurowire

Global NANOTECHNOLOGY IN MEDICAL APPLICATIONS Statistics, CAGR, Outlook, and Covid-19 Impact 2016 The Bisouv Network – The Bisouv Network

Posted on February 14, 2021 by Prof Baldwin

Nanotechnology in Medical Applications: The Global Market

This report discusses the implications of technology and commercial trends in the context of the current size and growth of the pharmaceutical market, both in global terms and analyzed by the most important national markets. The important technologies supporting nanomedicine are reviewed, and the nature and structure of the nanomedicine industry are discussed with profiles of the leading 60+ companies, including recent merger and acquisition (M&A) activity. Five-year sales forecasts are provided for the national markets including the major therapeutic categories of products involved. Specific product categories quantified include diagnostics, cancer, CNS, anti-infective agents, cardiovasculars and anti-inflammatories.

Also Read:https://telegra.ph/Global-Dancewear-Market-Statistics-Development-and-Growth-2025-02-02

Report Includes:

Also Read: http://wiseguyes8.total-blog.com/global-china-digital-audio-broadcasting-dab-market-outlook-industry-analysis-and-prospect-2020-2026-22894697

An overview of the global markets for nanotechnology used in medical applications

Analyses of global market trends, with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022

A review of technologies involved, in-depth analysis of applications in practice, and evaluation of future or potential applications

Also Read: https://techsite.io/p/1944999

Information on many significant products in which the nano dimension has made a significant contribution to product effectiveness

A look at the regulatory environment, healthcare policies, demographics, and other factors that directly affect nanotechnology used in medicine

Analysis of the markets dynamics, specifically growth drivers, inhibitors, and opportunities

Coverage of strategies employed by companies specializing in nanomedicine to meet the challenges of this highly competitive marketSummary

Also Read:https://wiseguyreports12.blogspot.com/2021/02/global-china-digital-audio-broadcasting.html

Nano-enabled medical products began appearing on the market over a decade ago, and some have become best-sellers in their therapeutic categories. The principal areas in which nanomedical products have made an impact are cancer, CNS diseases, cardiovascular disease and infection control. The Summary Table gives estimates of the historical and current markets for these nanomedicine areas with a forecast through 2022.

The U.S. market is by far the largest in the global nanomedicine market and is set to continue to dominate the world marketplace; however, other national markets are expected to increase their shares over the next five years.

Reasons for Doing the Study

Global Nanorobots Market Research Report Covers (COVID-19 Analysis) Industry Research, Drivers, Top Trends, Global Analysis And Forecast to 2027 -…

Posted on November 10, 2020 by Prof Baldwin

Global Nanorobots Market Report Provides Detailed Study Of Industry Players, Business Strategies, Latest Developmental Trends, And Market Growth Rate

The global Nanorobots market report offers a thorough study of the market in the estimated period. The important players Bruker, Jeol, Thermo Fisher, Ginkgo Bioworks, Oxford Instruments, Ev Group, Imina Technologies, Toronto Nano Instrumentation, Klocke Nanotechnik, Kleindiek Nanotechnik, Xidex, Synthace, Park Systems, Smaract, Nanonics Imaging, Novascan Technologies, Angstrom Advanced, Hummingbird Scientific, Nt-Mdt Spectrum Instruments, Witecin the global Nanorobots market are mentioned along with their strong points as well as weak points in this report. It covers almost all aspects of the global Nanorobots market including challenges, demand, drivers, and opportunities. The report reviews the impact of these aspects on every market region as well. The value chain analysis and vendor list are also included in the global Nanorobots market report.

Ask For Free Sample PDF of Nanorobots Market Report

{We Provide Free Sample copy as per your Research Requirement, also including COVID 19 impact analysis}

The global Nanorobots market research report emphasizes the presentation of the in-depth market segments {Nanomanipulator, Bio-Nanorobotics, Magnetically Guided, Bacteria-Based}; {Nanomedicine, Biomedical}. The Nanorobots market is assessed on the basis of revenue (USD Million) as well. The performance of the important players, vendors, and suppliers influencing the market is also incorporated in the global Nanorobots market research report. The majority of the information, together with projected statistics, is presented in the report with the help of tables and graphics. This presentation technique helps the user to understand the market scenario in an easy way.

Various practical tools are used for assessing the development of the global Nanorobots market in the future period. The global Nanorobots market report offers an outline of the market on a global level. It helps users to decide their next business move and propel their businesses. The index growth and competitive framework of the global Nanorobots market over the projected period is involved while reviewing the Nanorobots market. The global Nanorobots market is also bifurcated regionally North America (the U.S., Canada, and Mexico), South America (Brazil, Argentina, Chile, Colombia), Europe (Spain, Russia, Germany, Italy, France, and UK), Asia-Pacific (Japan, Korea, India, China, Australia, and South-east Asia), The Middle East and Africa (Egypt, South Africa, GCC Countries) as well.

Enquire about COVID-19 Updates for This Report:https://www.marketdataanalytics.biz/global-nanorobots-market-industry-trends-and-forecast-to-2027-19156.html#inquiry-for-buying

Major Questions Answered in Report:1. Which are the growth factors likely to help the market reach to the next level?2. What is the expected growth rate during the forecast period?3. What are the latest opportunities and challenges for Nanorobots market in the future?4. Which are the key market players?

The global Nanorobots market is studied in terms of technology, topography, and consumers. The report also covers the market volume during the estimated period. The distinctiveness of the global Nanorobots market research report is the representation of the Nanorobots market at both the global and regional level.

Key Reasons for Purchasing Global Nanorobots Market Report:

New approaches and latest development trend that describe the structure of the market Advanced market breakdown structure Historical data and future market scope In-depth market analysis based on statistics, growth stimulators, and market developments Statistical data representation through figurative, numerical, and theoretical elaboration Report provides insight of the business and sales activities Key competitive players and regional distribution will help find prospective market analytics Report will strengthen the investors decision-making processes

To get more information on this Premium Report::https://www.marketdataanalytics.biz/global-nanorobots-market-industry-trends-and-forecast-to-2027-19156.html

See original here:
Global Nanorobots Market Research Report Covers (COVID-19 Analysis) Industry Research, Drivers, Top Trends, Global Analysis And Forecast to 2027 -...

Post COVID-19 Return to Growth Will Witness Growing Diabetic Population Emerge Into a Big Opportunity – GlobeNewswire

Posted on November 19, 2020 by Prof Baldwin

New York, Nov. 19, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Foot Care Products Industry" - https://www.reportlinker.com/p090579/?utm_source=GNW Foot is a simple-looking yet complex structure of the human body made up of 26 bones and 33 joints and a complicated network of arteries, veins, and tendons. Feet are important for mobility, and better quality of life. As per studies, on average an individual walks about 100,000 miles in his lifetime. Foot care plays an important role in the overall foot health and following a good foot care regimen guarantees a comfortable foot all the time. Foot care refers to taking special preventative measures to stay away from foot problems such as cuts, calluses, sores and bunions. Foot care products are used for providing remedial and preventive foot and ankle care. Foot care products can help in treating a wide range of foot problems, including nail health, finger pain, toe pain, and heel pain. These problems can occur due to disease complications, general wear and tear, injury, or simply ill-fitting shoes. Rapidly changing lifestyle and fashion trends have significantly increased the exposure of the skin of the feet, thereby increasing the demand for foot care products. These products are more popular among women given the rising trend of open shoes and sandals. Consumers are now looking for sloughing scrubs, creams, cleansing lotions, and ointments for foot care that can deliver immediate results.

In the post COVID-19 period, growth will be driven by the aging population; high prevalence of diabetes; and growing awareness over the importance and interrelationship of foot and body mechanics that influence mobility, body posture, gait and balance. The shift towards preventive care in a bid to reduce healthcare costs and debilitating foot amputations in late-stage diabetic foot infections is helping drive demand for preventive foot care solutions. Complications due to diabetes are emerging into a massive healthcare burden driven by the epidemic increase in diabetes prevalence worldwide. Diabetic foot ulcers remain the leading cause of diabetic complication, already ranking among the top 10 cause of global disability, doctors visits & hospital admissions. Podology clinics where foot care is provided by professional podologists are poised to mushroom into a big opportunity foot care products. Proactive & preventive self-management foot care practices by patients will drive demand for consumer food care products designed for at-home consumption. Despite the availability of several products such as diabetic shoes that are designed to prevent high pressure points that could in turn lead to foot ulcers, scientists and researchers continue to push boundaries in this space with development of innovative, less-intrusive products that can both prevent and manage foot conditions in diabetics. One such area that has witnessed significant focus in recent years is Smart Socks, which help detect early signs of pressure on feet or other ailments that can lead to formation of diabetic foot ulcers. Research institutions and independent researchers have shown tremendous belief in the potential these socks have in the offing, and have made considerable progress to this end. Smart socks, which integrate temperature sensors, are capable of detecting infections through changes in temperature.

The launch of innovative and effective cosmetic foot care products such as foot mousse, electronic foot exfoliator, gel heel socks, cracked heel balm, rough skin remover, foot moisturizers, and massage creams, among others are helping encourage consumer spending. Natural and organic foot creams featuring potent ingredients such as vitamin e, coconut oil, glycerin, sea salts, shea butter, aloe-vera, papaya gel and cooling mints will grow in popularity. Women, given their unique genetic predisposition to foot ailments, represent the largest consumer cluster for foot care products. In addition, the rise of the new metropolitan male will drive demand for male foot care solutions. Advances in materials, 3d orthotics and fashionable orthotic footwear will also help expand revenue opportunities in the market. Asia-Pacific, a major market, will be led by factors such as growing emphasis of the educated middle class population on maintaining healthy feet that compliment high fashion footwear and the ensuing demand for cosmetic foot care solutions; rising incidence of foot infections such as scytalidium and dermatophytes due to improper hygiene standards; and rise in the number of patients with peripheral vascular diseases, neuropathy, hypothyroidism, diabetes and obesity that increase the risk of foot disorders.

Competitors identified in this market include, among others,

Read the full report: https://www.reportlinker.com/p090579/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE I-1

II. EXECUTIVE SUMMARY II-1

1. MARKET OVERVIEW II-1 Impact of Covid-19 and a Looming Global Recession II-1 Foot Care Products Market: A Prelude II-2 Foot Facts & Figures II-3 Foot Care Product Categories II-4 Market Outlook II-5 Geographic Landscape II-6 Geographic Landscape World Brands II-8

2. FOCUS ON SELECT PLAYERS II-9

3. MARKET TRENDS & DRIVERS II-11 Growing Focus on Self Care Boost OTC Foot Care Products II-11 Exhibit 1: Frequency of Foot Care Products Usage: 2019 II-11 Manufacturers Focus on Enabling Self-Care, Educating Customers II-12 Women: An Important Consumer Cluster II-12 Exhibit 2: Reasons for Using Foot Care Products among Women II-13 Rising Interest in Grooming Among Men Signals Opportunities II-14 Exhibit 3: Foot Care Products Usage Frequency (In %) Among Male Consumers by Age Group II-14 Product Innovations Steer Growth II-15 Growing Use of Natural and Organic Ingredients II-17 Nanomedicine to Improve Anti-Fungal Treatment II-17 E-Retailing Expands Growth Opportunities II-18 Exhibit 4: Factors Influencing Online Purchase Decision - Percentage Share Breakdown by Consumer Preferences II-19 Significance of Foot-Care in Diabetic Population II-19 Alarming Levels of Diabetes Incidence Worldwide Drives Demand for Foot Care Products II-20 Exhibit 5: World Diabetes and Population Statistics (2019, 2030 & 2045) II-21 Exhibit 6: World Diabetes Prevalence (2000-2019) II-22 Smart Socks: The Future of Diabetic Foot Care? II-22 Obese Population: A Weighty Market Driver II-23 Exhibit 7: Obesity Prevalence Rate (%) in Select Countries for the Years 2019 and 2030P II-25 Aging Population Offers Growth Prospects II-26 Exhibit 8: Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050 II-27 Emerging Middle Class in Developing Countries to Fuel Market II-27 Exhibit 9: Global Middle Class Population (In Million) by Region for the Years 2020, 2025 and 2030 II-28 Natural Remedies Remain a Challenge II-29 GENERAL FOOT PROBLEMS II-29

4. GLOBAL MARKET PERSPECTIVE II-31 Table 1: World Current & Future Analysis for Foot Care Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-31

Table 2: World Historic Review for Foot Care Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-32

Table 3: World 15-Year Perspective for Foot Care Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2020 & 2027 II-33

Table 4: World Current & Future Analysis for Foot Creams by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-34

Table 5: World Historic Review for Foot Creams by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-35

Table 6: World 15-Year Perspective for Foot Creams by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 II-36

Table 7: World Current & Future Analysis for Foot Cleansing Lotions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-37

Table 8: World Historic Review for Foot Cleansing Lotions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-38

Table 9: World 15-Year Perspective for Foot Cleansing Lotions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 II-39

Table 10: World Current & Future Analysis for Slough Scrub Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-40

Table 11: World Historic Review for Slough Scrub Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-41

Table 12: World 15-Year Perspective for Slough Scrub Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 II-42

Table 13: World Current & Future Analysis for Foot Repair Ointments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-43

Table 14: World Historic Review for Foot Repair Ointments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-44

Table 15: World 15-Year Perspective for Foot Repair Ointments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 II-45

Table 16: World Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-46

Table 17: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-47

Table 18: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 II-48

Table 19: World Current & Future Analysis for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-49

Table 20: World Historic Review for Medical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-50

Table 21: World 15-Year Perspective for Medical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 II-51

Table 22: World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 II-52

Table 23: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 II-53

Table 24: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2020 & 2027 II-54

III. MARKET ANALYSIS III-1

GEOGRAPHIC MARKET ANALYSIS III-1

UNITED STATES III-1 Market Overview III-1 Growing Incidence of Diabetes Boost Prospects for Foot Care Creams III-1 Exhibit 10: Diabetes and Population Statistics in North America and Caribbean Region (2019, 2030 & 2045) III-3 Exhibit 11: Diabetes Prevalence by Ethnicity: 2019 III-3 Exhibit 12: Diabetes Prevalence in the US: Percentage Share Breakdown of Number of Diabetics by Age Group for 2019 III-4 Aging Population Support Growth III-4 Exhibit 13: Population of 65+ Age Group (in Thousands) in the US for 2019 and 2030 III-4 Alarming Rise in Obesity to Drive Demand III-5 A Glance at Obesity Statistics III-5 Exhibit 14: Prevalence of Obesity Among Adults (20 and above) in the US: 2000 III-6 Rise in Incidence of Athlete?s foot to Drive Antifungal Cream Sales III-6 Market Analytics III-7 Table 25: USA Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-7

Table 26: USA Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-8

Table 27: USA 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-9

Table 28: USA Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-10

Table 29: USA Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-11

Table 30: USA 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-12

CANADA III-13 Table 31: Canada Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-13

Table 32: Canada Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-14

Table 33: Canada 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-15

Table 34: Canada Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-16

Table 35: Canada Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-17

Table 36: Canada 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-18

JAPAN III-19 Table 37: Japan Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-19

Table 38: Japan Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-20

Table 39: Japan 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-21

Table 40: Japan Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-22

Table 41: Japan Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-23

Table 42: Japan 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-24

CHINA III-25 Market Overview III-25 Market Analytics III-26 Table 43: China Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-26

Table 44: China Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-27

Table 45: China 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-28

Table 46: China Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-29

Table 47: China Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-30

Table 48: China 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-31

EUROPE III-32 Market Overview III-32 Exhibit 15: Diabetes and Population Statistics in Europe (2019, 2030 & 2045) III-32 Market Analytics III-33 Table 49: Europe Current & Future Analysis for Foot Care Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 III-33

Table 50: Europe Historic Review for Foot Care Products by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-34

Table 51: Europe 15-Year Perspective for Foot Care Products by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2020 & 2027 III-35

Table 52: Europe Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-36

Table 53: Europe Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-37

Table 54: Europe 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-38

Table 55: Europe Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-39

Table 56: Europe Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-40

Table 57: Europe 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-41

FRANCE III-42 Table 58: France Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-42

Table 59: France Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-43

Table 60: France 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-44

Table 61: France Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-45

Table 62: France Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-46

Table 63: France 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-47

GERMANY III-48 Table 64: Germany Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-48

Table 65: Germany Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-49

Table 66: Germany 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-50

Table 67: Germany Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-51

Table 68: Germany Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-52

Table 69: Germany 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-53

ITALY III-54 Table 70: Italy Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-54

Table 71: Italy Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-55

Table 72: Italy 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-56

Table 73: Italy Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-57

Table 74: Italy Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-58

Table 75: Italy 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-59

UNITED KINGDOM III-60 Market Overview III-60 Diabetic Foot Ulcers in UK III-60 Market Analytics III-61 Table 76: UK Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-61

Table 77: UK Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-62

Table 78: UK 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-63

Table 79: UK Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-64

Table 80: UK Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-65

Table 81: UK 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-66

SPAIN III-67 Table 82: Spain Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-67

Table 83: Spain Historic Review for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-68

Table 84: Spain 15-Year Perspective for Foot Care Products by Product - Percentage Breakdown of Value Sales for Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products for the Years 2012, 2020 & 2027 III-69

Table 85: Spain Current & Future Analysis for Foot Care Products by Application - Medical and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-70

Table 86: Spain Historic Review for Foot Care Products by Application - Medical and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 III-71

Table 87: Spain 15-Year Perspective for Foot Care Products by Application - Percentage Breakdown of Value Sales for Medical and Other Applications for the Years 2012, 2020 & 2027 III-72

RUSSIA III-73 Table 88: Russia Current & Future Analysis for Foot Care Products by Product - Foot Creams, Foot Cleansing Lotions, Slough Scrub Products, Foot Repair Ointments and Other Products Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 III-73

How Nanomedicine is Going Green and Fighting Superbugs – CareDash News

Posted on February 19, 2020 by Prof Baldwin

Nanomaterials are materials with one dimension less than 100 nanometers. A nanometer is one-billionth of a meter. Professor Thomas Webster directs the Nanomedicine Laboratory at Northeastern University. His lab designs, synthesizes, and evaluates nanomaterials for various medical implant applications. CareDash CEO and Managing Editor Ted Chan interviewed Dr. Webster about nanotech innovation.

We focus on the synthesis, design, and evaluation of nanomaterials (that is, tubes, particles, etc. with dimensions usually less than 100 nm) in medicine. Specifically, we were the first group to demonstrate increased tissue growth (such as bone, cartilage, vascular, bladder, nervous system, etc.) on nanomaterials compared to conventional implants. We were also the first group to report decreased infection on nanomaterials compared to conventional implants, even without the use of drugs. We have also been pioneering the use of implantable nanosensors to detect disease, communicate such information to a handheld device, and kill the disease on-demand.

As just one example, we have a growing alarming number of antibiotic-resistant infections that are crippling our healthcare system. In fact, the U.S. Centers for Disease Control has predicted that more people will die from antibiotic-resistant infections than all cancers combined by 2050. We created this problem, and we can solve it. So, in simple terms, we are killing bacteria using nanoparticles, but not antibiotics. We can even kill antibiotic-resistant bacteria with nanoparticles, whereas antibiotics fail. Decreasing infection from any bacteria, especially antibiotic-resistant bacteria, will significantly increase health.

In addition to those medical advances mentioned above (implantable sensors, nanoparticles that can kill antibiotic-resistant bacteria, nanomaterials to increase tissue growth, etc.), I am particularly excited about green nanomedicine.

Green nanomedicine is where we can use natural materials to create medical devices and nanoparticles. This is important since a significant portion of the "plastic island" in the Pacific Ocean is composed of plastics from the medical community, yet very few people are studying green biomaterials or green nanomedicine. We are here at Northeastern Nanomedicine Laboratory. We have been creating green medical devices and green nanoparticles, which is saving our environment and are more effective in their function than the respective conventional materials.

Persistence. We have started over 13 companies with over 23 FDA approved implants. Research is hard enough, but getting the funding to commercialize your products is even harder. I have learned throughout my career in so many ways never to give up, and if you believe in technology, persist until it is saving human lives.

Dr. Webster is a Keynote Speaker at the 2ndBiomedical Engineering and Instrumentation Summit(BEIS 2020), a conference organized to promote awareness and enhance research in biomedical engineering. BEIS 2020 will be held on July 20-22, 2020, in Boston, MA.

Disclosure: CareDash is a media partner of the BEIS Summit at which Dr. Webster is a keynote speaker in 2020. Dr. Webster and CareDash have no financial affiliation.

You can also tweet us questions and comments@caredash.

Read this article:
How Nanomedicine is Going Green and Fighting Superbugs - CareDash News

Oxford Performance Materials’ OsteoFab 3D Printed PEKK Technology Focus of Study Published in The Spine Journal – OrthoSpineNews

Posted on February 21, 2020 by Prof Baldwin

SOUTH WINDSOR, CONN. (PRWEB)FEBRUARY 17, 2020

Oxford Performance Materials, Inc. (OPM), an industry leader in advanced materials science and high-performance additive manufacturing (HPAM), announced today the publication of A Comparative Study of Three Biomaterials in an Ovine Defect Model: A TETRAfuse PEKK Study in The Spine Journal. 1,2,3 This study examined the in vivo material characteristics of polyetheretherketone (PEEK), titanium-coated PEEK, and 3D printed polyetherketoneketone (PEKK) in a sheep model. In comparison with PEEK, the PEKK implants displayed bone ingrowth, no fibrotic tissue formation, a significant increase in bony apposition over time, and a significantly higher push-out strength.

Conventionally, PEEK and Ti-coated PEEK have been used as standard biomaterials for implants like spinal interbody cages, but recent shortcomings in these materials have led to adoption of newer, more innovative technologies. Although PEEK shows an elastic modulus comparable to that of cortical bone, literature has illustrated that it consistently prompts a fibrotic and inflammatory tissue response, preventing it from integrating with host tissue. And while titanium exhibits similar osseointegrative properties when compared to PEKK, it is substantially stiffer than cortical bone and it is radiopaque, which makes bone fusion assessments difficult as the bone/implant interface is often obscured in post-operative imaging. With titanium coated PEEK implants, these drawbacks still exist but with the added risks of delamination of the titanium coating, subsidence, and the generation of wear debris.

The results reported by The Spine Journal were gratifying and support the comparative benefits of 3D printed PEKK implants that we have been hearing from surgeons for some time, now, said Scott DeFelice, CEO. OPMs OsteoFab technology platform is increasingly recognized as a best of solution for CMF and spinal implants, and we will be launching our unique 3D printed suture anchor product in the coming weeks.

3D printed PEKK delivers high mechanical integrity, radiographic visibility, and osseointegration, as well as inherent antibacterial characteristics.4 In this Spine Journal study, PEKK demonstrated a significantly higher push-out force when compared to PEEK at 8 and 16 weeks post-implantation and also had notably greater bone attachment following pushout when compared to PEEK and Ti-coated PEEK. From a histological standpoint, 3D printed PEKK also showed substantial bone growth. Within a 2mm radius of the implant, 3D printed PEKK exhibited the highest bone ongrowth percentage when compared to PEEK and Ti-coated PEEK at both the 8- and 16-week endpoints.

By directly comparing the three implant materials in an in vivo model, the study showed clear evidence of the performance characteristics at the bone-implant interface. In this instance, 3D printed PEKK presented a high propensity for bone-ingrowth, no radiographic interference, and a material structure that allowed for an increase of integration of cancellous bone into the implant. In a clinical scenario, 3D printed PEKK implants could improve the effectiveness of spinal fusion procedures by promoting osseointegration and decreasing the chance of complications associated with PEEK and Ti-coated PEEK.

Since 2013, OPM has been manufacturing patient-specific cranial and facial implant devices that have been distributed world-wide. In addition to over 2,300 craniomaxillofacial implants, OPM has 3D printed over 70,000 OsteoFab implants under a number of 510(k) clearances and just recently entered the sports medicine arena with a soft tissue fixation device. As the pendulum shifts away from traditional material solutions, OsteoFab 3D printed PEKK is proving to be a robust alternative with a rapidly growing user base.

About Oxford Performance Materials, Inc.

Oxford Performance Materials was founded in 2000 to exploit and commercialize the worlds highest performing thermoplastic, PEKK (poly-ether-ketone-ketone). OPMs Materials business has developed a range of proprietary, patented technologies for the synthesis and modification of a range of PAEK polymers that are sold under its OXPEKK brand for biomedical and industrial applications. The Company is a pioneer in 3D printing. OPM Biomedicals OsteoFab technology is in commercial production in numerous orthopedic implant applications, including cranial, facial, spinal, and sports medicine devices. OPM is the first and only company to receive FDA 510(k) clearance to manufacture 3D printed patient-specific polymeric implants and has six 510(k) clearances in its portfolio. OPM Industrial produces 3D printed OXFAB production parts for highly demanding applications in the energy, transportation and semiconductor markets. OXFAB structures offer significant weight, cost, and time-to-market reductions that are defined in a set of specified performance attributes in the exhaustive OPM B-Basis database, developed in conjunction with NASA. For more information, please visit:http://www.oxfordpm.com

Company Contact:Willow JohndrowDirector of Marketing860.656.9442

References1. Cheng, PhD B, Jaffee S, Swink I, Averick, PhD S, Horvath S, Zhukauskas, PhD R et al. A Comparative Study of Three Biomaterials in an Ovine Bone Defect Model: A TETRAfuse PEKK Study. The Spine Journal. 2019. doi: 10.1016/j.spinee.2019.10.0032. RESULTS paragraph from the Study abstract reads: PEKK implants demonstrated bone ingrowth, no radiographic interference, no fibrotic tissue membrane formation, significant increase in bony apposition over time, and significantly higher push-out strength compared to standard PEEK. The PEKK implant displayed bone growth characteristics comparable to Ti-coated PEEK with significant improvements in implant integrity and radiographic properties.3. Note: TETRAfuse is a Registered Trademark of RTI Surgical, Inc. and the tradename for RTIs spinal implants that are additively manufactured by Oxford Performance Materials, Inc. using OPMs proprietary OsteoFab technology platform. TETRAfuse was awarded a 2019 MedTech Breakthrough Award for Best New Technology Solution Orthopedics and a 2018 Spine Technology Award from Orthopedics This Week.4. Wang M, Bhardwaj B, Webster T; Antibacterial properties of PEKK for orthopedic applications. Intl Journal of Nanomedicine. 2017: 12 6471-6476.

Read the original post:
Oxford Performance Materials' OsteoFab 3D Printed PEKK Technology Focus of Study Published in The Spine Journal - OrthoSpineNews

Healthcare Nanotechnology (Nanomedicine) Market Share, Segments by Size, Growth, Market Share, Types, Key Vendors with Development and Scope, Forecast…

Posted on November 5, 2020 by Prof Baldwin

Global Healthcare Nanotechnology (Nanomedicine) Market report provides a detailed analysis of market overview and trends, key segments, business strategies, developments of key players, the future outlook of the market. This research report gives comprehensive knowledge and valuable insights about the Healthcare Nanotechnology (Nanomedicine) market. The report contains an in-depth analysis of the market size, growth, opportunities, product types, and services. The market is expected to grow at a different CAGR value during the forecast period of 2018-2023.

The report offers an overview of revenue, market share, demand, restraints, and supply of data during the projected year. These factors are becoming increasingly important in the present scenario.

Get a Sample Copy of the Report at https://www.absolutereports.com/enquiry/request-sample/13102426

Top Key Manufactures of Healthcare Nanotechnology (Nanomedicine) Market:

Market Dynamics :

> Drivers Rising Incidence of Cardiovascular Diseases Increasing Research Funding Rising Awareness of Nanomedicine Application Increasing Applications in Oncology

> Restraints High Costs of Nanotechnology-Based Medical Devices Time-Consuming Product Approval

> Opportunities

> Key Challenges

Regional Analysis:

This Healthcare Nanotechnology (Nanomedicine) report analysis segmented by geography, market share and revenues, market size, technologies, growth rate and forecast period of the following regions are including:

United States, Canada, Mexico, United Kingdom, France, Germany, Italy, Spain, Rest of Europe, India, China, Japan, Australia, South Korea, Rest of APAC, GCC, South Africa, Rest of MEA, Brazil,Argentina, Rest of South Africa

The Healthcare Nanotechnology (Nanomedicine) market contains industry challenges, business expansion plans, competitive landscape, key development, and accurate country-wise volume analysis and region-wise market size analysis of the global market. This detailed assessment of the market will help the company increase efficiency.

Inquire or Share Your Questions If Any Before the Purchasing This Report https://www.absolutereports.com/enquiry/pre-order-enquiry/13102426

Key Developments in the Market::> Major developments in 2017 covered in the report> And the latest major developments in 2018 covered in the report

Key Reasons to Purchase this Report:

Purchase this Report (Price 4250 USD for a Single-User License) https://www.absolutereports.com/checkout/13102426

Detailed TOC of Global Healthcare Nanotechnology (Nanomedicine) Market Growth, Trends, Challenges and Forecast (2018 2023)

1 Healthcare Nanotechnology (Nanomedicine) Market Introduction

1.1 Study Deliverables

1.2 General Study Assumptions

2 Research Methodology

2.1 Introduction

2.2 Analysis Methodology

2.3 Study Phases

2.4 Econometric Modelling

3 Executive Summary

4 Healthcare Nanotechnology (Nanomedicine) Market Overview and Trends

4.1 Introduction

4.2 Healthcare Nanotechnology (Nanomedicine) Market Trends

4.3 Porters Five Force Framework

Continued

For Detailed TOC https://www.absolutereports.com/TOC/13102426#TOC

Name: Ajay More

Phone: US +14242530807/ UK +44 20 3239 8187

Email: [emailprotected]

Our Other Reports:

Global Flex Fuel Engine Market Status and Outlook: 2020 Business Development Plans by Companies, Industry Trends and Restraints, Market Share and Revenue till 2026

Global Smart Parking Sensors Market Status and Outlook: 2020 Business Development Plans by Companies, Industry Trends and Restraints, Market Share and Revenue till 2026

Global Electrical Enclosure Equipments Market Report Insights Forecast to 2020-2025, Market Segmentation, Impact of COVID-19 on Global Industry, Key Distributors/Retailers

Gift Cards Market 2020 Status and Outlook by Regions, Market opportunities, Market Challenges, Risk and Industry Trends, Manufacture Cost Structure

Veterinary Orthopedic Implants Market 2020 by Business Strategy, Development History, Types, Applications and Trends, Growth Factors by Regions, Market Size and Share till 2026

Global Food Packaging Technology and Equipment Market Demand Status 2020 Share, Global Market Trends, Current Industry News, Business Growth, Top Regions Update by Forecast to 2026

Medical & Lab Refrigerators Market Industry Growth and Demand, Product Overview, Company Profiles and Recent Business Development, Forecast to 2020-2026

Continue reading here:
Healthcare Nanotechnology (Nanomedicine) Market Share, Segments by Size, Growth, Market Share, Types, Key Vendors with Development and Scope, Forecast...

Nanorobots Market Outlook by Drivers, Forecast and Covid-19 Impact by 2026 | Bruker, Jeol, Thermo Fisher and Others – KYT24

Posted on November 10, 2020 by Prof Baldwin

An innovative research study has been offered by Futuristic Reports, offering a comprehensive analysis of the Global Nanorobots Market where users can get an advantage from the comprehensive market research report with all the essential useful information. This is the newest report, covering the existing COVID-19 impact on the Nanorobots market. It has fetched along with numerous changes in market conditions. This segment also provides the Nanorobots scope of different applications and types that can potentially influence the future market. The comprehensive statistics are based on current trends and historical milestones.

This report also delivers an analysis of production volume about the global Nanorobots market and each type from 2020 to 2026. The Nanorobots report explicitly features the market share, company profiles, regional viewpoint, product portfolio, recent developments, newest strategic analysis, key players in the market, deals, circulation chain, manufacturing, production, and newest market entrants. The existing Nanorobots market players, brand value, popular products, demand and supply, and other significant factors identified with the market help players will better understand the market scenario.

Get Exclusive Sample Copy on Nanorobots Market at: https://www.futuristicreports.com/request-sample/80216

Impact of COVID-19 on Nanorobots Market

The report also contains the effect of the ongoing worldwide pandemic, i.e., COVID-19, on the Nanorobots Market and what the future holds for it. It offers an analysis of the impacts of the epidemic on the international market. The epidemic has immediately interrupted the requirement and supply series. The Nanorobots report also assesses the economic effect on firms and economic demands. Futuristic Reports has accumulated advice from several delegates of this Nanorobots business and has engaged from the secondary and primary research to extend the customers with strategies and data to combat industry struggles throughout and after the COVID-19 pandemic.

Some of the key players operating in this market include:

(Bruker, Jeol, Thermo Fisher, Ginkgo Bioworks, Oxford Instruments, Ev Group, Imina Technologies, Toronto Nano Instrumentation, Klocke Nanotechnik, Kleindiek Nanotechnik, Xidex, Synthace, Park Systems, Smaract, Nanonics Imaging, Novascan Technologies, Angstrom Advanced, Hummingbird Scientific, Nt-Mdt Spectrum Instruments, Witec, Nanorobots)

Based on Product Type, Nanorobots market report displays the production, profits, cost, and market segment and growth rate of each type, covers:

Nanomanipulator Bio-Nanorobotics Magnetically Guided Bacteria-Based Nanorobots Industry Vertical

Based on end users/applications, the Nanorobots market report focuses on the status and viewpoint for major applications/end users, sales volume, market share, and growth rate for each application. This can be divided into:

Nanomedicine Biomedical Others

Grab Your Report at an Impressive Discount! Please click here: https://www.futuristicreports.com/check-discount/80216

The report offers a comprehensive assessment of the progression and other Nanorobots market features in significant regions, including South Korea, Taiwan, North America, Europe, Canada, Germany, France, Southeast Asia, Mexico, and Brazil, Pacific, and Latin America. U.S., U.K., Italy, Russia, China, Japan, etc.

Features the following key factors:

Some of the Key Questions Answered in this Report:

Inquire More About This Report @ https://www.futuristicreports.com/send-an-enquiry/80216

Our Other Reports:

Vaginal Pessary Market Growth, Trend, Statistics and Covid-19 Impact by 2026 | Smiths Medical, MedGyn, Kangge Medical and Others

Alizarin Market Outlook by Drivers, Forecast and Covid-19 Impact by 2026 | CDH, RICCA Chemical, Amadis Chemical and Others

Garment Steamer Market Share, Size Status, Forecast Analysis and Covid-19 Impact by 2026 | Midea, HOMETOP, HAAN and Others

WomenS Golf Shoes Market Qualitative, Quantitative Research on Leading Players and Covid-19 Impact by 2026 | ECCO, Dexter, Skechers and Others

Futuristic Reports

Name: Mark RiveraTel: +1-408-520-9037Email: [emailprotected]

See the article here:
Nanorobots Market Outlook by Drivers, Forecast and Covid-19 Impact by 2026 | Bruker, Jeol, Thermo Fisher and Others - KYT24

Impact Of Covid-19 on Nanomedicine Market 2020 Industry Challenges, Business Overview and Forecast Research Study 2026 – Crypto Daily

Posted on October 6, 2020 by Prof Baldwin

Manhattan, New York, Analytical Research Cognizance: TheNanomedicineMarketreport is based on the basis of product type, application and end-user during the truncated forecast period. The detailed study further offers a broad interpretation on the Nanomedicine market based on a systematic analysis of the market from a variety of reliable sources and thorough data points. Furthermore, the report sheds a light on the Global scale segmenting the market space across various districts, appropriate distribution channels, generated income and a generalized market space.

This intelligence and 2025 forecasts Nanomedicine industry report further exhibits a pattern of analyzing previous data sources gathered from reliable sources and set a precedented growth trajectory for the Nanomedicine market. The report also focuses on a comprehensive market revenue streams along with growth patterns, analytics focused on market trends, and the overall volume of the market.

Request Sample of Global Nanomedicine Market Report @https://www.arcognizance.com/enquiry-sample/923566

Finally, the report provides detailed profile and data information analysis of leading Augmented Reality Company.

This report covers leading companies associated in Nanomedicine Market @GE Healthcare, Johnson & Johnson, Mallinckrodt plc, Merck & Co. Inc., Nanosphere Inc., Pfizer Inc., Sigma-Tau Pharmaceuticals Inc., Smith & Nephew PLC, Stryker Corp, Teva Pharmaceutical Industries Ltd., UCB (Union chimique belge) S.A

Region Segmentation:North America (U.S., Canada, Mexico)Europe (Germany, U.K., France, Italy, Russia, Spain etc.)Asia-Pacific (China, India, Japan, Southeast Asia etc.)South America (Brazil, Argentina etc.)Middle East & Africa (Saudi Arabia, South Africa etc.)

On the basis of types, the Nanomedicine market is primarily split into:Regenerative Medicine, In-vitro & In-vivo Diagnostics, Vaccines, Drug Delivery

On the basis of applications, the market covers:Clinical Cardiology, Urology, Genetics, Orthopedics, Ophthalmology

Some of the major factors contributing to the growth of the global Nanomedicine market:

Nanomedicine Market Report Structure at a Glance:

Access Global Nanomedicine Market Report @https://www.arcognizance.com/report/global-nanomedicine-market-status-and-future-forecast-2015-2025

Table of Content:

Note:Our report does take into account the impact of corona virus pandemic and dedicates qualitative as well as quantitative sections of information within the report that emphasizes the impact of COVID-19.

As this pandemic is ongoing and leading to dynamic shifts in stocks and businesses worldwide, we take into account the current condition and forecast the market data taking into consideration the micro and macroeconomic factors that will be affected by the pandemic.

About us:Analytical Research Cognizance (ARC) is a trusted hub for research reports that critically renders accurate and statistical data for your business growth. Our extensive database of examined market reports places us amongst the best industry report firms. Our professionally equipped team further strengthens ARCs potential. ARC works with the mission of creating a platform where marketers can have access to informative, latest and well researched reports. To achieve this aim our experts tactically scrutinize every report that comes under their eye.

See the original post:
Impact Of Covid-19 on Nanomedicine Market 2020 Industry Challenges, Business Overview and Forecast Research Study 2026 - Crypto Daily

R&D Activities to Fast-track the Growth of the Healthcare Nanotechnology (Nanomedicine) Market Between 2015 2021 – The Daily Chronicle

Posted on September 19, 2020 by Prof Baldwin

Persistence Market Research recently published a market study that sheds light on the growth prospects of the global Healthcare Nanotechnology (Nanomedicine) market during the forecast period (20XX-20XX). In addition, the report also includes a detailed analysis of the impact of the novel COVID-19 pandemic on the future prospects of the Healthcare Nanotechnology (Nanomedicine) market. The report provides a thorough evaluation of the latest trends, market drivers, opportunities, and challenges within the global Healthcare Nanotechnology (Nanomedicine) market to assist our clients arrive at beneficial business decisions.

The Healthcare Nanotechnology (Nanomedicine) market study is a well-researched report encompassing a detailed analysis of this industry with respect to certain parameters such as the product capacity as well as the overall market remuneration. The report enumerates details about production and consumption patterns in the business as well, in addition to the current scenario of the Healthcare Nanotechnology (Nanomedicine) market and the trends that will prevail in this industry.

Request Sample Report @ https://www.persistencemarketresearch.co/samples/6370

What pointers are covered in the Healthcare Nanotechnology (Nanomedicine) market research study?

The Healthcare Nanotechnology (Nanomedicine) market report Elucidated with regards to the regional landscape of the industry:

The geographical reach of the Healthcare Nanotechnology (Nanomedicine) market has been meticulously segmented into United States, China, Europe, Japan, Southeast Asia & India, according to the report.

The research enumerates the consumption market share of every region in minute detail, in conjunction with the production market share and revenue.

Also, the report is inclusive of the growth rate that each region is projected to register over the estimated period.

The Healthcare Nanotechnology (Nanomedicine) market report Elucidated with regards to the competitive landscape of the industry:

The competitive expanse of this business has been flawlessly categorized into companies such as

Key players in the global nanomedicine market include: Abbott Laboratories, CombiMatrix Corporation, GE Healthcare, Sigma-Tau Pharmaceuticals, Inc., Johnson & Johnson, Mallinckrodt plc, Merck & Company, Inc., Nanosphere, Inc., Pfizer, Inc., Celgene Corporation, Teva Pharmaceutical Industries Ltd., and UCB (Union chimique belge) S.A.

Key geographies evaluated in this report are:

Key features of this report

Request Report Methodology @ https://www.persistencemarketresearch.co/methodology/6370

Exclusive details pertaining to the contribution that every firm has made to the industry have been outlined in the study. Not to mention, a brief gist of the company description has been provided as well.

Substantial information subject to the production patterns of each firm and the area that is catered to, has been elucidated.

The valuation that each company holds, in tandem with the description as well as substantial specifications of the manufactured products have been enumerated in the study as well.

The Healthcare Nanotechnology (Nanomedicine) market research study conscientiously mentions a separate section that enumerates details with regards to major parameters like the price fads of key raw material and industrial chain analysis, not to mention, details about the suppliers of the raw material. That said, it is pivotal to mention that the Healthcare Nanotechnology (Nanomedicine) market report also expounds an analysis of the industry distribution chain, further advancing on aspects such as important distributors and the customer pool.

The Healthcare Nanotechnology (Nanomedicine) market report enumerates information about the industry in terms of market share, market size, revenue forecasts, and regional outlook. The report further illustrates competitive insights of key players in the business vertical followed by an overview of their diverse portfolios and growth strategies.

For any queries get in touch with Industry Expert @ https://www.persistencemarketresearch.co/ask-an-expert/6370

Some of the Major Highlights of TOC covers:

Excerpt from:
R&D Activities to Fast-track the Growth of the Healthcare Nanotechnology (Nanomedicine) Market Between 2015 2021 - The Daily Chronicle

Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region – Good Night, Good Hockey

Posted on August 26, 2020 by Prof Baldwin

Nanomedicine Marketwas valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2026, at CAGR of XX% during forecast period of 2019 to 2026.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/39223

Nanomedicine is an application of nanotechnology, which are used in diagnosis, treatment, monitoring, and control of biological systems. Nanomedicine usages nanoscale manipulation of materials to improve medicine delivery. Therefore, nanomedicine has facilitated the treatment against various diseases. The nanomedicine market includes products that are nanoformulations of the existing drugs and new drugs or are nanobiomaterials. The research and development of new devices as well as the diagnostics will become, more effective, enabling faster response and the ability to treat new diseases are likely to boost the market growth.

The nanomedicine markets are driven by factors such as developing new technologies for drug delivery, increase acceptance of nanomedicine across varied applications, rise in government support and funding, the growing need for therapies that have fewer side effects and cost-effective. However, long approval process and risks associated with nanomedicine (environmental impacts) are hampering the market growth at the global level. An increase in the out-licensing of nanodrugs and growth of healthcare facilities in emerging economies are likely to create lucrative opportunities in the nanomedicine market.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Nanomedicine Market Segmentation Analysis:Based on the application, the nanomedicine market has been segmented into cardiovascular, neurology, anti-infective, anti-inflammatory, and oncology. The oncology segment held the dominant market share in 2018 and is projected to maintain its leading position throughout the forecast period owing to the rising availability of patient information and technological advancements. However, the cardiovascular and neurology segment is projected to grow at the highest CAGR of XX% during the forecast period due to presence of opportunities such as demand for specific therapeutic nanovectors, nanostructured stents, and implants for tissue regeneration.

Nanomedicine Market Regional Analysis:Geographically, the Nanomedicine market has been segmented into North America, the Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the Nanomedicine market in 2018 due to the rising presence of patented nanomedicine products, the availability of advanced healthcare infrastructure and the rapid acceptance of nanomedicine. The market in Asia Pacific is expected to expand at a high CAGR of XX% during the forecast period thanks to rise in number of research grants and increase in demand for prophylaxis of life-threatening diseases. Moreover, the rising investments in research and development activities for the introduction of advanced therapies and drugs are predicted to accelerate the growth of this region in the near future.

Nanomedicine Market Competitive landscapeMajor Key players operating in this market are Abbott Laboratories, CombiMatrix Corporation, General Electric Company, Sigma-Tau Pharmaceuticals, Inc, and Johnson & Johnson. Manufacturers in the nanomedicine are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.

The objective of the report is to present a comprehensive analysis of Nanomedicine Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market are presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Nanomedicine Market dynamics, structure by analyzing the market segments and project the Nanomedicine Market size. Clear representation of competitive analysis of key players By Type, Price, Financial position, Product portfolio, Growth strategies, and regional presence in the Nanomedicine Market make the report investors guide.Scope of the Nanomedicine Market:

Nanomedicine Market by Modality:

Diagnostics TreatmentsNanomedicine Market by Diseases:

Oncological Diseases Infectious Diseases Cardiovascular Diseases Orthopedic Disorders Neurological Diseases Urological Diseases Ophthalmological Diseases Immunological DiseasesNanomedicine Market by Application:

Neurology Cardiovascular Anti-Inflammatory Anti-Infectives OncologyNanomedicine Market by Region:

Asia Pacific North America Europe Latin America Middle East AfricaNanomedicine Market Major Players:

Abbott Laboratories CombiMatrix Corporation General Electric Company Sigma-Tau Pharmaceuticals, Inc Johnson & Johnson Mallinckrodt plc. Merck & Company, Inc. Nanosphere, Inc. Pfizer, Inc. Teva Pharmaceutical Industries Ltd. Celgene Corporation UCB (Union Chimique Belge) S.A. AMAG Pharmaceuticals Nanospectra Biosciences, Inc. Arrowhead Pharmaceuticals, Inc. Leadiant Biosciences, Inc. Epeius Biotechnologies Corporation Cytimmune Sciences, Inc.

Browse Full Report with Facts and Figures Report at:https://www.maximizemarketresearch.com/market-report/nanomedicine-market/39223/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website:www.maximizemarketresearch.com

Excerpt from:
Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region - Good Night, Good Hockey

Oral Contrast Agent Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: GE Healthcare (US), Bracco Imaging (Italy),…

Posted on September 3, 2020 by Prof Baldwin

InForGrowth has added Latest Research Report on Oral Contrast Agent Market 2020 Future Growth Opportunities, Development Trends, and Forecast 2026. The Global Oral Contrast Agent Market market report cover an overview of the segments and sub-segmentations including the product types, applications, companies & regions. This report describes overall Oral Contrast Agent Market size by analyzing historical data and future projections.

The report features unique and relevant factors that are likely to have a significant impact on the Oral Contrast Agent market during the forecast period. This report also includes the COVID-19 pandemic impact analysis on the Oral Contrast Agent market. This report includes a detailed and considerable amount of information, which will help new providers in the most comprehensive manner for better understanding. The report elaborates the historical and current trends molding the growth of the Oral Contrast Agent market

Get Exclusive Sample Report on Oral Contrast Agent Market is available at https://inforgrowth.com/sample-request/6544762/oral-contrast-agent-market

Market Segmentation:

The segmentation of the Oral Contrast Agent market has been offered on the basis of product type, application, Major Key Players and region. Every segment has been analyzed in detail, and data pertaining to the growth of each segment has been included in the analysis

Top Players Listed in the Oral Contrast Agent Market Report areGE Healthcare (US), Bracco Imaging (Italy), Bayer HealthCare (Germany), Guerbet (France), Lantheus (US), Daiichi Sankyo (Japan), Unijules Life Sciences (India), J.B. Chemicals and Pharmaceuticals (India), Spago Nanomedicine (Sweden), Taejoon Pharm (South Korea), Jodas (India), Magnus Health (India).

Based on type, report split into Barium-based Contrast Media, Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media.

Based on Application Oral Contrast Agent market is segmented into Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders.

Get Chance of 20% Extra Discount, If your Company is Listed in Above Key Players List;https://inforgrowth.com/discount/6544762/oral-contrast-agent-market

Impact of COVID-19: Oral Contrast Agent Market report analyses the impact of Coronavirus (COVID-19) on the Oral Contrast Agent industry. Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 180+ countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Oral Contrast Agent market in 2020

COVID-19 can affect the global economy in 3 main ways: by directly affecting production and demand, by creating supply chain and market disturbance, and by its financial impact on firms and financial markets.

Get the Sample ToC to understand the CORONA Virus/COVID19 impact and be smart in redefining business strategies. https://inforgrowth.com/CovidImpact-Request/6544762/oral-contrast-agent-market

Oral Contrast AgentMarket: Key Questions Answered in Report

The research study on the Oral Contrast Agentmarket offers inclusive insights about the growth of the market in the most comprehensible manner for a better understanding of users. Insights offered in the Oral Contrast Agentmarket report answer some of the most prominent questions that assist the stakeholders in measuring all the emerging possibilities.

FOR ALL YOUR RESEARCH NEEDS, REACH OUT TO US AT:Address: 6400 Village Pkwy suite # 104, Dublin, CA 94568, USAContact Name: Rohan S.Email:[emailprotected]Phone: +1-909-329-2808UK: +44 (203) 743 1898

See the rest here:
Oral Contrast Agent Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: GE Healthcare (US), Bracco Imaging (Italy),...

Nanomedicine Market Top Companies Analysis To growing at CAGR of 12.6% by 2023 – PharmiWeb.com

Posted on September 14, 2020 by Prof Baldwin

Pune, Maharashtra, India, September 14 2020 (Wiredrelease) Allied Analytics :UPDATE AVAILABLE ON-DEMAND

The research report published by Allied Market Report states that the global nanomedicine market is estimated to reach $261,063 million by 2023. The report provides an in-depth analysis of growth factors, opportunities, market trends, key segments, and competitive landscape. Current market conditions and the future scenario of various regions have been analyzed in the report to help market players in devising expansion strategies. Moreover, it includes country-wise analysis of each region. Product portfolio and business segments of leading market players outline the competitive scenario. The report provides insights to help investors, stakeholders, and new entrants to determine potential opportunities and tap on them to gain competitive advantage. The drug delivery segment accounted for nearly two-fifths share of the global market in 2016.

Nanomedicine is an application of nanotechnology that deals in the prevention & treatment of diseases in humans. This technology uses submicrometer-sized particles for diagnosis, treatment, and prevention of diseases. Nanomedicines are advantageous over generic drugs in several aspects such as, to reduce renal excretion, improve the ability of drugs to accumulate at pathological sites, and enhance the therapeutic index of drugs. Thus, nanomedicine is used in a wide range of applications that include aerospace materials, cosmetics, and medicine.

To Get the Sample Copy of Report Visit @ https://www.alliedmarketresearch.com/request-sample/2021

The global market is driven by increase in the development of nanotechnology-based drugs, advantages of nanomedicine in various healthcare applications, and growth in need of therapies with fewer side effects. However, long approval process and risks associated with nanomedicine (environmental impacts) restrain the market growth. In addition, growth of healthcare facilities in emerging economies is anticipated to provide numerous opportunities for the market growth.

The vaccines segment is expected to register a significant CAGR of 13.2% throughout the forecast period. The treatment segment accounted for about fourth-sevenths share in the global market in 2016, accounting for the highest share during the forecast period. This is due to the high demand for therapeutics among patient and rise in the incidence of chronic diseases.

The neurological diseases segment is expected to grow at the highest CAGR of 13.9% during the forecast period, owing to high demand for brain monitoring & treatment devices and drugs. The oncological diseases segment accounted for the highest revenue in 2016, with one-third share of the global market, and is expected to maintain its dominance throughout the forecast period.

In 2016, Asia-Pacific and LAMEA collectively accounted for about one-fourth share of the global market, and is expected to continue this trend due to increased adoption of nanomedicines, especially in China, India, and the other developing economies. In addition, rise in investments by key players in the field of nanomedicines is key driving factor of the Asia-Pacific market.

Inquire Before Buying @ https://www.alliedmarketresearch.com/purchase-enquiry/2021

The Major Key Players Are:

Abbott Laboratories CombiMatrix Corporation General Electric Company Sigma-Tau Pharmaceuticals, Inc. Johnson & Johnson Mallinckrodt plc Merck & Company, Inc. Nanosphere, Inc. Pfizer, Inc. Teva Pharmaceutical Industries Ltd.

The Other Prominent Players Are:

Celgene Corporation UCB (Union Chimique Belge) S.A. AMAG Pharmaceuticals Nanospectra Biosciences, Inc. Arrowhead Pharmaceuticals, Inc. Leadiant Biosciences, Inc. Epeius Biotechnologies Corporation Gilead Cytimmune Sciences, Inc.

Key Findings of the Nanomedicine Market:

The regenerative medicine segment is anticipated to grow at the highest CAGR of 13.8% during the forecast period. The U.S. was the major shareholder in the North America nanomedicine market in 2016. The oncological diseases segment accounted for one-third share in the global market in 2016, and is expected to maintain this trend throughout the forecast period. China occupied one-third share of the Asia-Pacific nanomedicine market in 2016, registering a CAGR of 14.3% from 2017 to 2023. The treatment segment dominated the market with about fourth-sevenths of the overall share of the market in 2016.

Simillar Reports:

Contact Lenses Market Global Opportunity Analysis and Industry Forecast, 2020-2027

Healthcare Payer Solution Market Global Opportunity Analysis and Industry Forecast, 2020-2027

Blood Group Typing Market Global Opportunity Analysis and Industry Forecast, 2020-2027

Computed Tomography (CT) Market Global Opportunity Analysis and Industry Forecast, 2020-2027

About Us:

Allied Market Research (AMR) is a full-service market research and business -consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of Market Research Reports and Business Intelligence Solutions. AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesToll Free (USA/Canada):+1-800-792-5285, +1-503-894-6022, +1-503-446-1141UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060Fax: +1-855-550-5975help@alliedmarketresearch.comWeb:https://www.alliedmarketresearch.com

This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at contact@wiredrelease.com.

Follow this link:
Nanomedicine Market Top Companies Analysis To growing at CAGR of 12.6% by 2023 - PharmiWeb.com

Global Healthcare Nanotechnology (Nanomedicine) Market Worth $475B by 2027 – Therapeutics Will Account for $369B – Benzinga

Posted on August 5, 2020 by Prof Baldwin

Dublin, Aug. 05, 2020 (GLOBE NEWSWIRE) -- The "Healthcare Nanotechnology (Nanomedicine) - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering.

The publisher brings years of research experience to this 9th edition of the report. The 190-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Global Healthcare Nanotechnology (Nanomedicine) Market to Reach $475.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Healthcare Nanotechnology (Nanomedicine) estimated at US$183.9 Billion in the year 2020, is projected to reach a revised size of US$475.2 Billion by 2027, growing at a CAGR of 14.5% over the analysis period 2020-2027.

Therapeutics, one of the segments analyzed in the report, is projected to record a 14.1% CAGR and reach US$369.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Regenerative medicine segment is readjusted to a revised 15.7% CAGR for the next 7-year period.

The U.S. Market is Estimated at $54.3 Billion, While China is Forecast to Grow at 14% CAGR

The Healthcare Nanotechnology (Nanomedicine) market in the U.S. is estimated at US$54.3 Billion in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$82.8 Billion by the year 2027 trailing a CAGR of 14% over the analysis period 2020 to 2027.

Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.8% and 12.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.7% CAGR.

In-vitro diagnostics Segment to Record 16.3% CAGR

In the global In-vitro diagnostics segment, USA, Canada, Japan, China and Europe will drive the 16.1% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$5.7 Billion in the year 2020 will reach a projected size of US$16.2 Billion by the close of the analysis period.

China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$56.9 Billion by the year 2027.

Competitors identified in this market include, among others:

Total Companies Profiled: 46

For more information about this report visit https://www.researchandmarkets.com/r/moa2yk

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Read the rest here:
Global Healthcare Nanotechnology (Nanomedicine) Market Worth $475B by 2027 - Therapeutics Will Account for $369B - Benzinga

Futurist Transhuman News Blog

Category Archives: Nanomedicine

Nanomedicine Market Shares, Strategies and Forecast Worldwide, 2017 to 2023 – The Haitian-Caribbean News Network

Botulinum Toxin Market to Reach US$ 8,718.7 Mn by 2026, Rise in number of cases of migraine is expected to drive the market – BioSpace

Nanomedicine Against Malaria: Use of Poly-based Nanovectors for the Drug Delivery to Plasmodium – Video

Panel – The Horizon of Nanomedicine and Targeted Drug Delivery – Video

Global Healthcare Nanotechnology (Nanomedicine) Market 2021 Production, Revenue, Price and Gross Margin Analysis with Forecasts Jumbo News – Jumbo…

Using Hybrid Nanoparticles to Deliver siRNA to Different Cell Types – AZoNano

Nano-Medical Device Market To Set Phenomenal Growth and Trends By 2020-2027 | Stryker, PerkinElmer, Nektar Therapeutics, Affymetrix – Eurowire

Global NANOTECHNOLOGY IN MEDICAL APPLICATIONS Statistics, CAGR, Outlook, and Covid-19 Impact 2016 The Bisouv Network – The Bisouv Network

Global Nanorobots Market Research Report Covers (COVID-19 Analysis) Industry Research, Drivers, Top Trends, Global Analysis And Forecast to 2027 -…

Post COVID-19 Return to Growth Will Witness Growing Diabetic Population Emerge Into a Big Opportunity – GlobeNewswire

How Nanomedicine is Going Green and Fighting Superbugs – CareDash News

Oxford Performance Materials’ OsteoFab 3D Printed PEKK Technology Focus of Study Published in The Spine Journal – OrthoSpineNews

Healthcare Nanotechnology (Nanomedicine) Market Share, Segments by Size, Growth, Market Share, Types, Key Vendors with Development and Scope, Forecast…

Nanorobots Market Outlook by Drivers, Forecast and Covid-19 Impact by 2026 | Bruker, Jeol, Thermo Fisher and Others – KYT24

Impact Of Covid-19 on Nanomedicine Market 2020 Industry Challenges, Business Overview and Forecast Research Study 2026 – Crypto Daily

R&D Activities to Fast-track the Growth of the Healthcare Nanotechnology (Nanomedicine) Market Between 2015 2021 – The Daily Chronicle

Nanomedicine Market: Industry Analysis and forecast 2026: By Modality, Diseases, Application and Region – Good Night, Good Hockey

Oral Contrast Agent Market 2020 | Know the Latest COVID19 Impact Analysis And Strategies of Key Players: GE Healthcare (US), Bracco Imaging (Italy),…

Nanomedicine Market Top Companies Analysis To growing at CAGR of 12.6% by 2023 – PharmiWeb.com

Global Healthcare Nanotechnology (Nanomedicine) Market Worth $475B by 2027 – Therapeutics Will Account for $369B – Benzinga